The patient had two episodes of flare-up of posterior uveitis, the initial one possibly due to a sub-optimal immunosuppressive regime that allowed the persistence of inflammatory cytokines such as TNF-alpha, which was subsequently addressed with adalimumab and systemic methotrexate. Here, TNF is linked to posterior uveitis.